AI steps in to predict liver disease treatment success
NCT ID NCT07378202
Summary
This study aims to use artificial intelligence (AI) to predict how well patients with autoimmune hepatitis will respond to standard treatments. Researchers will analyze data from thousands of patients to build and test computer models that can forecast treatment success at 6 and 12 months. The goal is to help doctors personalize treatment plans earlier, potentially leading to better long-term health for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE HEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Else Kroener Fresenius Center for Digital Health, Technical University Dresden
Dresden, Germany
-
Hannover Medical School
Hanover, 30625, Germany
Conditions
Explore the condition pages connected to this study.